Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies

Bibliography

• GUENGERICH F: Cytochrome P450 enzymes. American Scientist (1993) 81(5):440-447.
   Web of Science ®Google Scholar
• WATKINS P: Role of cytochromes P450 in drug metabolism and hepatotoxicity. Semin. Liver Dis. (1990) 10(4):235-250.
   PubMed Web of Science ®Google Scholar
• GONZALEZ FJ: Molecular genetics of the P450 superfamily. Pharmacol. Ther. (1990) 45(1):1-38.
   PubMed Web of Science ®Google Scholar
• GUENGERICH FP: Cytochrome P450 3A4: regulation and role in drug metabolism. Ann. Rev. Pharmacol. Toxicol. (1999) 39:1-17.
   PubMed Web of Science ®Google Scholar
• KRISHNA DR, KLOTZ U: Extrahepatic metabolism of drugs in humans. Clin. Pharmacokinet. (1994) 26(2):144-160.
   PubMed Web of Science ®Google Scholar
• HAKKOLA J, PELKONEN O, PASANENM, RAUNIO H: Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity. Crit. Rev. Toxicol. (1998) 28(1):35-72.
   PubMed Web of Science ®Google Scholar
• PELKONEN O, RAUNIO H: Metabolic activation of toxins: tissue-specific expression and metabolism in target organs. Environ. Health Perspect. (1997) 105(Suppl.4):767-774.
   PubMed Web of Science ®Google Scholar
• RAUNIO H, HAKKOLA J, HUKKANENJ etal.: Expression of xenobiotic-metabolizing cytochrome P450s in human pulmonary tissues. Arch. Toxicol. Suppl. (1998) 20:465-469.
   PubMedGoogle Scholar
• SPATZENEGGER M, JAEGER W: Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metab. Rev. (1995) 27(3):397-417.
   PubMed Web of Science ®Google Scholar
• RILEY RJ, KENNA JG: Cellular models for ADMET predictions and evaluation of drugdrug interactions. Curr. Opin. Drug Discov. Devel. (2004) 7(1):86-99.
   PubMed Web of Science ®Google Scholar
• HUTZLER M, MESSING DM, WIENKERS LC: Predicting drugdrug interactions in drug discovery: where are we now and where are we going? Curr. Opin. Drug Discov. Devel. (2005) 8(1):51-58.
   PubMed Web of Science ®Google Scholar
• RILEY RJ: The potential pharmacological and toxicological impact of P450 screening. Curr. Opin. Drug Discov. Devel. (2001) 4(1):45-54.
   PubMedGoogle Scholar
• CASTELL J, GMEZ-LECHN M: Invitro methods in pharmaceutical research. Academic Press, London, UK (1997).
   Google Scholar
• RODRIGUES AD: Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes. Biochem. Pharmacol. (1999) 57(5):465-480.
   PubMed Web of Science ®Google Scholar
• GMEZ-LECHN M, DONATO T, PONSODA X etal.: Isolation, culture and use of human hepatocytes in drug research. In: InVitro Methods in Pharmaceutical Research. J Castell etal. (Eds), Academic Press, New York, USA (1997):129-154.
   Google Scholar
• GOMEZ-LECHON M, CASTELL J: Isolation and culture of human hepatocytes. In: The hepatocyte review. MN Berry, AM Edwards (Eds), Kluwer Academic Publishers, London, UK (2000):11-17.
   Google Scholar
• GOMEZ-LECHON MJ, DONATO MT, CASTELL JV, JOVER R: Human hepatocytes as a tool for studying toxicity and drug metabolism. Curr. Drug Metab. (2003) 4(4):292-312.
   PubMed Web of Science ®Google Scholar
• GOMEZ-LECHON MJ, DONATO MT, CASTELL JV, JOVER R: Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. Curr. Drug Metab. (2004) 5(5):443-462.
   PubMed Web of Science ®Google Scholar
• PONSODA X, PAREJA E, GOMEZ-LECHON MJ etal.: Drug biotransformation by human hepatocytes. Invitro/invivo metabolism by cells from the same donor. J. Hepatol. (2001) 34(1):19-25.
   PubMed Web of Science ®Google Scholar
• FISCHBACH M, CAO HW, DIEZIBANEZ M etal.: Maintenance of liver function in long term culture of hepatocytes following invitro or invivo Ha-rasEJ transfection. Cell Biol. Toxicol. (1991) 7(4):327-345.
   PubMed Web of Science ®Google Scholar
• BAYAD J, BAGREL D, SABOLOVIC N, MAGDALOU J, SIEST G: Expression and regulation of drug metabolizing enzymes in an immortalized rat hepatocyte cell line. Biochem. Pharmacol. (1991) 42(7):1345-1351.
   PubMed Web of Science ®Google Scholar
• ISOM HC, WOODWORTH CD, MENG Y etal.: Introduction of the ras oncogene transforms a simian virus 40-immortalized hepatocyte cell line without loss of expression of albumin and other liver-specific genes. Cancer Res. (1992) 52(4):940-948.
   PubMed Web of Science ®Google Scholar
• ANDERSON K, ANDREWS R, YIN L etal.: Cytotoxicity of xenobiotics and expression of glutathione-S-transferases in immortalised rat hepatocyte cell lines. Hum. Exp. Toxicol. (1998) 17(3):131-137.
   PubMed Web of Science ®Google Scholar
• SUN EL, FEENSTRA KL, BELL FP etal.: Biotransformation of lifibrol (U-83860) to mixed glyceride metabolites by rat and human hepatocytes in primary culture. Drug Metab. Dispos. (1996) 24(2):221-231.
   PubMed Web of Science ®Google Scholar
• OLINGA P, MEREMA M, HOF IH etal.: Effect of human liver source on the functionality of isolated hepatocytes and liver slices. Drug Metab. Dispos. (1998) 26(1):5-11.
   PubMed Web of Science ®Google Scholar
• DONATO MT, CASTELL JV, GOMEZ-LECHON MJ: Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models. J. Hepatol. (1999) 31(3):542-549.
   PubMed Web of Science ®Google Scholar
• JIGOREL E, LE VEE M, BOURSIER-NEYRET C, BERTRANDM, FARDEL O: Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes. Drug Metab. Dispos. (2005) 33(10):1418-1422.
   PubMed Web of Science ®Google Scholar
• GOMEZ-LECHON MJ, LOPEZ P, DONATO T etal.: Culture of human hepatocytes from small surgical liver biopsies. Biochemical characterization and comparison with invivo. InVitro Cell Dev. Biol. (1990) 26(1):67-74.
   PubMed Web of Science ®Google Scholar
• HEWITT NJ, BUHRING KU, DASENBROCK J etal.: Studies comparing invivo:invitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte cultures. Drug Metab. Dispos. (2001) 29(7):1042-1050.
   PubMed Web of Science ®Google Scholar
• OHYAMA K, NAKAJIMA M, NAKAMURA S etal.: A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor. Drug Metab. Dispos. (2000) 28(11):1303-1310.
   PubMed Web of Science ®Google Scholar
• KIM HM, HAN SB, HYUN BH etal.: Functional human hepatocytes: isolation from small liver biopsy samples and primary cultivation with liver-specific functions. J. Toxicol. Sci. (1995) 20(5):565-578.
   PubMedGoogle Scholar
• PONSODA X, DONATO MT, PEREZ-CATALDO G, GOMEZ-LECHON MJ, CASTELL JV: Drug metabolism by cultured human hepatocytes: how far are we from the invivo reality? Altern Lab. Anim. (2004) 32(2):101-110.
   PubMed Web of Science ®Google Scholar
• GOMEZ-LECHON MJ, PONSODA X, BORT R, CASTELL JV: The use of cultured hepatocytes to investigate the metabolism of drugs and mechanisms of drug hepatotoxicity. Altern Lab. Anim. (2001) 29(3):225-231.
   PubMed Web of Science ®Google Scholar
• PELKONEN O, MAENPAA J, TAAVITSAINEN P, RAUTIO A, RAUNIO H: Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica (1998) 28(12):1203-1253.
   PubMed Web of Science ®Google Scholar
• WHITLOCK JP Jr: Induction of cytochrome P4501A1. Ann. Rev. Pharmacol. Toxicol. (1999) 39:103-125.
   PubMed Web of Science ®Google Scholar
• WAXMAN DJ: P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR and PPAR. Arch. Biochem. Biophys. (1999) 369(1):11-23.
   PubMed Web of Science ®Google Scholar
• HINES RN, LUO Z, CRESTEIL T etal.: Molecular regulation of genes encoding xenobiotic-metabolizing enzymes: mechanisms involving endogenous factors. Drug Metab. Dispos. (2001) 29(5):623-633.
   PubMed Web of Science ®Google Scholar
• RONIS MJJ, INGELMAN-SUNDBERG M: Induction of human drug-metabolizing enzymes: mechanisms and implications. In: Handbook of drug metabolism. TF Woolf (Ed.), Marcel Dekker, Inc., New York, US (1999):239-262.
   Google Scholar
• STROM SC, PISAROV LA, DORKO K etal.: Use of human hepatocytes to study P450 gene induction. Methods Enzymol. (1996) 272:388-401.
   PubMed Web of Science ®Google Scholar
• DONATO MT, CASTELL JV: Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on invitro studies. Clin. Pharmacokinet. (2003) 42(2):153-178.
   PubMed Web of Science ®Google Scholar
• KOSTRUBSKY VE, RAMACHANDRANV, VENKATARAMANAN R etal.: The use of human hepatocyte cultures to study the induction of cytochrome P450. Drug Metab. Dispos. (1999) 27(8):887-894.
   PubMed Web of Science ®Google Scholar
• CURI-PEDROSA R, DAUJAT M, PICHARD L etal.: Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture. J. Pharmacol. Exp. Ther. (1994) 269(1):384-392.
   PubMed Web of Science ®Google Scholar
• GERBAL-CHALOIN S, PASCUSSI JM, PICHARD-GARCIA L etal.: Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metab. Dispos. (2001) 29(3):242-251.
   PubMed Web of Science ®Google Scholar
• DAVID P, VIOLLON C, ALEXANDRE E etal.: Metabolic capacities in cultured human hepatocytes obtained by a new isolating procedure from non-wedge small liver biopsies. Hum. Exp. Toxicol. (1998) 17(10):544-553.
   PubMed Web of Science ®Google Scholar
• DONATO MT, GOMEZ-LECHON MJ, CASTELL JV: Effect of xenobiotics on monooxygenase activities in cultured human hepatocytes. Biochem. Pharmacol. (1990) 39(8):1321-1326.
   PubMed Web of Science ®Google Scholar
• DE SMET K, CAVIN C, VERCRUYSSEA, ROGIERS V: Collagen type I gel cultures of adult rat hepatocytes as a screening induction model for cytochrome P450-dependent enzymes. Altern. Lab. Anim. (2001) 29(2):179-192.
   PubMed Web of Science ®Google Scholar
• BEKEN S, VANHAECKE T, DE SMET K etal.: Collagen-gel cultures of rat hepatocytes: collagen-gel sandwich and immobilization cultures. Methods Mol. Biol. (1998) 107:303-309.
   PubMedGoogle Scholar
• KOEBE HG, PAHERNIK S, EYER P, SCHILDBERG FW: Collagen gel immobilization: a useful cell culture technique for long-term metabolic studies on human hepatocytes. Xenobiotica (1994) 24(2):95-107.
   PubMed Web of Science ®Google Scholar
• GOMEZ-LECHON MJ, JOVER R, DONATO T, PONSODA X, CASTELLJV: Expression of liver specific-genes in hepatocytes cultured in collagen gel matrix. Prog. Mol. Subcell. Biol. (2000) 25:89-104.
   PubMedGoogle Scholar
• GOMEZ-LECHON MJ, JOVER R, DONATO T etal.: Long-term expression of differentiated functions in hepatocytes cultured in three-dimensional collagen matrix. J. Cell. Physiol. (1998) 177(4):553-562.
   PubMed Web of Science ®Google Scholar
• LECLUYSE E, BULLOCK P, MADAN A, CARROLL K, PARKINSON A: Influence of extracellular matrix overlay and medium formulation on the induction of cytochrome P450 2B enzymes in primary cultures of rat hepatocytes. Drug Metab. Dispos. (1999) 27(8):909-915.
   PubMed Web of Science ®Google Scholar
• RODRIGUEZ-ANTONA C, JOVER R, GOMEZ-LECHON MJ, CASTELL JV: Quantitative RT-PCR measurement of human cytochrome P450s: application to drug induction studies. Arch. Biochem. Biophys. (2000) 376(1):109-116.
   PubMed Web of Science ®Google Scholar
• PEREZ G, TABARES B, JOVER R, GOMEZ-LECHON MJ, CASTELL JV: Semi-automatic quantitative RT-PCR to measure CYP induction by drugs in human hepatocytes. Toxicol. InVitro (2003) 17(5-6):643-649.
   PubMed Web of Science ®Google Scholar
• PELKONEN O: Human CYPs: invivo and clinical aspects. Drug Metab. Rev. (2002) 34(1-2):37-46.
   PubMed Web of Science ®Google Scholar
• MEYER UA: Pharmacogenetics and adverse drug reactions. Lancet (2000) 356(9242):1667-1671.
   PubMed Web of Science ®Google Scholar
• MEYER UA: Pharmacogenetics five decades of therapeutic lessons from genetic diversity. Nat. Rev. Genet (2004) 5(9):669-676.
   PubMed Web of Science ®Google Scholar
• INGELMAN-SUNDBERG M: Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. Trends Pharmacol. Sci. (2004) 25(4):193-200.
   PubMed Web of Science ®Google Scholar
• LIN J, LU A: Interindividual variability in inhibition and induction of cytochrome P450 enzymes. Ann. Rev. Pharmacol. Toxicol. (2001) 41:535-567.
   PubMed Web of Science ®Google Scholar
• LU AY: Drug-metabolism research challenges in the new millennium: individual variability in drug therapy and drug safety. Drug Metab. Dispos. (1998) 26(12):1217-1222.
   PubMed Web of Science ®Google Scholar
• LECLUYSE EL: Human hepatocyte culture systems for the invitro evaluation of cytochrome P450 expression and regulation. Eur. J. Pharm. Sci. (2001) 13(4):343-368.
   PubMed Web of Science ®Google Scholar
• DONATO MT, CASTELL JV, GOMEZ-LECHON MJ: Effect of model inducers on cytochrome P450 activities of human hepatocytes in primary culture. Drug Metab. Dispos. (1995) 23(5):553-558.
   PubMed Web of Science ®Google Scholar
• DONATO MT, GOMEZ-LECHON MJ, CASTELL JV: Drug metabolizing enzymes in rat hepatocytes co-cultured with cell lines. InVitro Cell Dev. Biol. (1990) 26(11):1057-1062.
   PubMed Web of Science ®Google Scholar
• PADGHAM CR, BOYLE CC, WANG XJ etal.: Alteration of transcription factor mRNAs during the isolation and culture of rat hepatocytes suggests the activation of a proliferative mode underlies their de-differentiation. Biochem. Biophys. Res. Commun. (1993) 197(2):599-605.
   PubMed Web of Science ®Google Scholar
• PADGHAM CR, PAINE AJ: Altered expression of cytochrome P450 mRNAs, and potentially of other transcripts encoding key hepatic functions, are triggered during the isolation of rat hepatocytes. Biochem. J. (1993) 289(Pt3):621-624.
   PubMed Web of Science ®Google Scholar
• RODRIGUEZ-ANTONA C, DONATOMT, BOOBIS A etal.: Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. Xenobiotica (2002) 32(6):505-520.
   PubMed Web of Science ®Google Scholar
• GEORGE J, GOODWIN B, LIDDLE C, TAPNER M, FARRELL G: Time-dependent expression of cytochrome P450 genes in primary cultures of well-differentiated human hepatocytes. J. Lab. Clin. Med. (1997) 129(6):638-648.
   PubMedGoogle Scholar
• LECLUYSE E, MADAN A, HAMILTONG etal.: Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. J. Biochem. Mol. Toxicol. (2000) 14(4):177-188.
   PubMed Web of Science ®Google Scholar
• ABRAMOVITZ M, ISHIGAKI S, LISTOWSKY I: Differential regulation of glutathione S-transferases in cultured hepatocytes. Hepatology (1989) 9(2):235-239.
   PubMed Web of Science ®Google Scholar
• FARDEL O, RATANASAVANH D, LOYER P, KETTERER B, GUILLOUZOA: Overexpression of the multidrug resistance gene product in adult rat hepatocytes during primary culture. Eur. J. Biochem. (1992) 205(2):847-852.
   PubMedGoogle Scholar
• RODRIGUEZ-ARIZA A, PAINE AJ: Rapid induction of NF-B binding during liver cell isolation and culture: inhibition by L-NAME indicates a role for nitric oxide synthase. Biochem. Biophys. Res. Commun. (1999) 257(1):145-148.
   PubMed Web of Science ®Google Scholar
• IBER H, CHEN Q, CHENG P, MORGAN E: Suppression of CYP2C11 gene transcription by interleukin-1 mediated by NF-B binding at the transcription start site. Arch. Biochem. Biophys. (2000) 377(1):187-194.
   PubMed Web of Science ®Google Scholar
• JOVER R, BORT R, GOMEZ-LECHON MJ, CASTELL JV: Re-expression of C/EBP- induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells. FEBS Lett. (1998) 431(2):227-230.
   PubMed Web of Science ®Google Scholar
• CEREGHINI S: Liver-enriched transcription factors and hepatocyte differentiation. FASEB J. (1996) 10(2):267-282.
   PubMed Web of Science ®Google Scholar
• GONZALEZ FJ, LEE YH: Constitutive expression of hepatic cytochrome P450 genes. FASEB J. (1996) 10(10):1112-1117.
   PubMed Web of Science ®Google Scholar
• FERRINI JB, OURLIN JC, PICHARD L, FABRE G, MAUREL P: Human hepatocyte cultures. In: Cytochrome P450 Protocols: Methods in Molecular Biology. IR Phillips, E Shephard (Eds), Human Press, Inc., Totowa, NJ, USA (1998) 107:341-352.
   Google Scholar
• RUNGE D, RUNGE D, JAGER D etal.: Serum-free, long-term cultures of human hepatocytes: maintenance of cell morphology, transcription factors, and liver-specific functions. Biochem. Biophys. Res. Commun. (2000) 269(1):46-53.
   PubMed Web of Science ®Google Scholar
• RUNGE D, MICHALOPOULOS G, STROM S, RUNGE D: Recent advances in human hepatocyte culture systems. Biochem. Biophys. Res. Commun. (2000) 274(1):1-3.
   PubMed Web of Science ®Google Scholar
• LOPEZ-GARCIA MP: Endogenous nitric oxide is responsible for the early loss of P450 in cultured rat hepatocytes. FEBS Lett. (1998) 438(3):145-149.
   PubMed Web of Science ®Google Scholar
• PERROT N, CHESNE C, DE WAZIERS I etal.: Effects of ethanol and clofibrate on expression of cytochrome P450 enzymes and epoxide hydrolase in cultures and cocultures of rat hepatocytes. Eur. J. Biochem. (1991) 200(1):255-261.
   PubMedGoogle Scholar
• LERCHE C, FAUTREL A, SHAW PM etal.: Regulation of the major detoxication functions by phenobarbital and 3-methylcholanthrene in co-cultures of rat hepatocytes and liver epithelial cells. Eur. J. Biochem. (1997) 244(1):98-106.
   PubMedGoogle Scholar
• DONATO MT, CASTELL JV, GOMEZ-LECHON MJ: Co-cultures of hepatocytes with epithelial-like cell lines: expression of drug-biotransformation activities by hepatocytes. Cell Biol. Toxicol. (1991) 7(1):1-14.
   PubMed Web of Science ®Google Scholar
• LI AP, GORYCKI PD, HENGSTLER JG etal.: Present status of the application of cryopreserved hepatocytes in the evaluation of xenobiotics: consensus of an international expert panel. Chem. Biol. Interact. (1999) 121(1):117-123.
   PubMed Web of Science ®Google Scholar
• DE SOUSA G, LANGOUET S, NICOLAS F etal.: Increase of cytochrome P450 1A and glutathione transferase transcripts in cultured hepatocytes from dogs, monkeys, and humans after cryopreservation. Cell Biol. Toxicol. (1996) 12(4-6):351-358.
   PubMed Web of Science ®Google Scholar
• ALEXANDRE E, VIOLLON-ABADIE C, DAVID P etal.: Cryopreservation of adult human hepatocytes obtained from resected liver biopsies. Cryobiology (2002) 44(2):103-113.
   PubMed Web of Science ®Google Scholar
• LI AP, LU C, BRENT JA etal.: Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. Chem. Biol. Interact. (1999) 121(1):17-35.
   PubMed Web of Science ®Google Scholar
• SKETT P, ROBERTS P, KHAN S: Maintenance of steroid metabolism and hormone responsiveness in cryopreserved dog, monkey and human hepatocytes. Chem. Biol. Interact. (1999) 121(1):65-76.
   PubMed Web of Science ®Google Scholar
• REINACH B, DE SOUSA G, DOSTERTP etal.: Comparative effects of rifabutin and rifampicin on cytochromes P450 and UDP-glucuronosyl-transferases expression in fresh and cryopreserved human hepatocytes. Chem. Biol. Interact. (1999) 121(1):37-48.
   PubMed Web of Science ®Google Scholar
• RIALLAND L, GUYOMARD C, SCOTTE M, CHESNE C, GUILLOUZOA: Viability and drug metabolism capacity of alginate-entrapped hepatocytes after cryopreservation. Cell Biol. Toxicol. (2000) 16(2):105-116.
   PubMed Web of Science ®Google Scholar
• HENGSTLER JG, UTESCH D, STEINBERG P etal.: Cryopreserved primary hepatocytes as a constantly available invitro model for the evaluation of human and animal drug metabolism and enzyme induction. Drug Metab. Rev. (2000) 32(1):81-118.
   PubMed Web of Science ®Google Scholar
• SILVA JM, DAY SH, NICOLL-GRIFFITH DA: Induction of cytochrome-P450 in cryopreserved rat and human hepatocytes. Chem. Biol. Interact. (1999) 121(1):49-63.
   PubMed Web of Science ®Google Scholar
• SKETT P, TYSON C, GUILLOUZO A, MAIER P: Report on the international workshop on the use of human invitro liver preparations to study drug metabolism in drug development. Held at Utrecht, The Netherlands, 6-8 September 1994. Biochem. Pharmacol. (1995) 50(2):280-285.
   PubMed Web of Science ®Google Scholar
• SCHEHRER L, REGAN JD, WESTENDORF J: UDS induction by an array of standard carcinogens in human and rodent hepatocytes: effect of cryopreservation. Toxicology (2000) 147(3):177-191.
   PubMed Web of Science ®Google Scholar
• COUNDOURIS JA, GRANT MH, ENGESET J, PETRIE JC, HAWKSWORTH GM: Cryopreservation of human adult hepatocytes for use in drug metabolism and toxicity studies. Xenobiotica (1993) 23(12):1399-1409.
   PubMed Web of Science ®Google Scholar
• MITRY RR, HUGHES RD, DHAWAN A: Progress in human hepatocytes: isolation, culture and cryopreservation. Semin. Cell Dev. Biol. (2002) 13(6):463-467.
   PubMed Web of Science ®Google Scholar
• MCGINNITY DF, SOARS MG, URBANOWICZ RA, RILEY RJ: Evaluation of fresh and cryopreserved hepatocytes as invitro drug metabolism tools for the prediction of metabolic clearance. Drug Metab. Dispos. (2004) 32(11):1247-1253.
   PubMed Web of Science ®Google Scholar
• LORETZ LJ, LI AP, FLYE MW, WILSONAG: Optimization of cryopreservation procedures for rat and human hepatocytes. Xenobiotica (1989) 19(5):489-498.
   PubMed Web of Science ®Google Scholar
• CORCOS L, WEISS MC: Phenobarbital, dexamethasone and benzanthracene induce several cytochrome P450 mRNAs in rat hepatoma cells. FEBS Lett. (1988) 233(1):37-40.
   PubMed Web of Science ®Google Scholar
• KARENLAMPI SO, TUOMI K, KORKALAINEN M, RAUNIO H: Induction of cytochrome P450IA1 in mouse hepatoma cells by several chemicals. Phenobarbital and TCDD induce the same form of cytochrome P450. Biochem. Pharmacol. (1989) 38(9):1517-1525.
   PubMed Web of Science ®Google Scholar
• KOBLIAKOV V, KULIKOVA L, SAMOILOV D, LANG MA: High expression of cytochrome P450 2a-5 (coumarin 7-hydroxylase) in mouse hepatomas. Mol. Carcinog. (1993) 7(4):276-280.
   PubMed Web of Science ®Google Scholar
• NAKAMA A, KURODA K, YAMADA A: Induction of cytochrome P450-dependent monooxygenase in serum-free cultured Hep G2 cells. Biochem. Pharmacol. (1995) 50(9):1407-1412.
   PubMed Web of Science ®Google Scholar
• ENOSAWA S, SUZUKI S, KAKEFUDA T, AMEMIYA H: Examination of 7-ethoxycoumarin deethylation and ammonia removal activities in 31 hepatocyte cell lines. Cell Transplant. (1996) 5(5Suppl.1):S39-S40.
   Google Scholar
• ROQUES M, BAGREL D, MAGDALOUJ, SIEST G: Expression of aryhydrocarbon hydroxylase, epoxide hydrolases, glutathione S-transferase and UDP-glucuronyltransferases in H5-6 hepatoma cells. Gen. Pharmacol. (1991) 4:677-684.
   Google Scholar
• DONATO MT, BASSI A, GMEZ-LECHN MJ etal.: Evaluation of the xenobiotic biotransformation capability of six rodent hepatoma cell lines in comparison with rat hepatocytes. InVitro Cell Dev. Biol. Anim. (1994) 30A:574-580.
   Google Scholar
• CORONEOS E, GORDON JW, KELLYSL, WANG PD, SIM E: Drug metabolising N-acetyltransferase activity in human cell lines. Biochim. Biophys. Acta (1991) 1073(3):593-599.
   PubMed Web of Science ®Google Scholar
• SUMIDA A, FUKUEN S, YAMAMOTO I etal.: Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR. Biochem. Biophys. Res. Commun. (2000) 267(3):756-760.
   PubMed Web of Science ®Google Scholar
• GOMEZ-LECHON MJ, DONATO T, JOVER R etal.: Expression and induction of a large set of drug-metabolizing enzymes by the highly differentiated human hepatoma cell line BC2. Eur. J. Biochem. (2001) 268(5):1448-1459.
   PubMedGoogle Scholar
• FABRE N, ARRIVET E, TRANCARD J etal.: A new hepatoma cell line for toxicity testing at repeated doses. Cell Biol. Toxicol. (2003) 19(2):71-82.
   PubMed Web of Science ®Google Scholar
• OCONNOR JE, MARTINEZ A, CASTELL JV, GOMEZ-LECHON MJ: Multiparametric characterization by flow cytometry of flow-sorted subpopulations of a human hepatoma cell line useful for drug research. Cytometry A (2005) 63(1):48-58.
   PubMedGoogle Scholar
• GRIPON P, RUMIN S, URBAN S etal.: Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl. Acad. Sci. USA (2002) 99(24):15655-15660.
   PubMed Web of Science ®Google Scholar
• HOHNE M, PIASECKI A, UMMELMANN E, PAUL D: Transformation of differentiated neonatal rat hepatocytes in primary culture by polyoma virus early region sequences. Oncogene (1987) 1(4):337-345.
   PubMed Web of Science ®Google Scholar
• OURLIN J, VILAREM M, DAUJAT M etal.: Lipid-mediated transfection of normal adult human hepatocytes in primary culture. Anal. Biochem. (1997) 247(1):34-44.
   PubMed Web of Science ®Google Scholar
• UENO T, MIYAMURA T, SAITO I, MIZUNO K: Immortalization of differentiated human hepatocytes by a combination of a viral vector and collagen gel culture. Hum. Cell (1993) 6(2):126-136.
   PubMedGoogle Scholar
• REDDEL RR, DE SILVA R, DUNCANEL etal.: SV40-induced immortalization and ras-transformation of human bronchial epithelial cells. Int. J. Cancer (1995) 61(2):199-205.
   PubMed Web of Science ®Google Scholar
• SHAY JW, WRIGHT WE, WERBIN H: Defining the molecular mechanisms of human cell immortalization. Biochim. Biophys. Acta (1991) 1072(1):1-7.
   PubMed Web of Science ®Google Scholar
• HOFFMANN B, PAUL D: Precocious induction of tyrosine aminotransferase mRNA by hydrocortisone in cultured fetal rat hepatocytes at different developmental stages. J. Cell. Physiol. (1990) 143(2):352-356.
   PubMed Web of Science ®Google Scholar
• KEMPE KC, ISOM HC, GREENE FE: Responsiveness of an SV40-immortalized hepatocyte cell line to growth hormone. Biochem. Pharmacol. (1995) 49(8):1091-1098.
   PubMed Web of Science ®Google Scholar
• PAUL D, HOHNE M, PINKERT C etal.: Immortalized differentiated hepatocyte lines derived from transgenic mice harboring SV40 T-antigen genes. Exp. Cell Res. (1988) 175(2):354-362.
   PubMed Web of Science ®Google Scholar
• COURJAULT-GAUTIER F, ANTOINE B, BENS M etal.: Activity and inducibility of drug-metabolizing enzymes in immortalized hepatocyte-like cells (mhPKT) derived from a L-PK/Tag1 transgenic mouse. Exp. Cell Res. (1997) 234(2):362-372.
   PubMed Web of Science ®Google Scholar
• SACK GH, JR.: Human cell transformation by simian virus 40-a review. InVitro (1981) 17(1):1-19.
   Google Scholar
• SACK GH Jr, OBIE C: Human cell transformation by simian virus 40. Biologic features of cloned lines. Exp. Cell Res. (1981) 134(2):425-432.
   PubMed Web of Science ®Google Scholar
• HOHNE MW, ZIEROTH S, VESER U, KAHL GF, SCHWARZ LR: Carcinogen-induced diploid hepatocytes: sensitive target cells for transformation by mutated c-Ha-ras oncogene. Mol. Carcinog. (1993) 7(3):180-189.
   PubMed Web of Science ®Google Scholar
• SIRICA AE: Immortalizing hepatocytes with truncated MET: a little bit of gene goes a long way. Hepatology (1997) 26(2):510-512.
   PubMedGoogle Scholar
• WEGE H, LE HT, CHUI MS etal.: Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Gastroenterology (2003) 124(2):432-444.
   PubMed Web of Science ®Google Scholar
• OSANAI M, OGAWA K, LEE GH: Phenobarbital causes apoptosis in conditionally immortalized mouse hepatocytes depending on deregulated c-myc expression: characterization of an unexpected effect. Cancer Res. (1997) 57(14):2896-2903.
   PubMed Web of Science ®Google Scholar
• NAKAMURA J, OKAMOTO T, SCHUMACHER IK etal.: Treatment of surgically induced acute liver failure by transplantation of conditionally immortalized hepatocytes. Transplantation (1997) 63(11):1541-1547.
   PubMed Web of Science ®Google Scholar
• YANAI N, SUZUKI M, OBINATA M: Hepatocyte cell lines established from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene. Exp. Cell Res. (1991) 197(1):50-56.
   PubMed Web of Science ®Google Scholar
• WU JC, MERLINO G, FAUSTO N: Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor-. Proc. Natl. Acad. Sci. USA (1994) 91(2):674-678.
   PubMed Web of Science ®Google Scholar
• AMICONE L, SPAGNOLI FM, SPATH G etal.: Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes. EMBO J. (1997) 16(3):495-503.
   PubMed Web of Science ®Google Scholar
• BULERA SJ, HAAS MJ, SATTLER CA, LIY, PITOT HC: Cell lines with heterogeneous phenotypes result from a single isolation of albumin-sv40 T-antigen transgenic rat hepatocytes. Hepatology (1997) 25(5):1192-1203.
   PubMed Web of Science ®Google Scholar
• CARTIER N, MIQUEROL L, TULLIEZM etal.: Diet-dependent carcinogenesis of pancreatic islets and liver in transgenic mice expressing oncogenes under the control of the L-type pyruvate kinase gene promoter. Oncogene (1992) 7(7):1413-1422.
   PubMed Web of Science ®Google Scholar
• CARTIER N, LACAVE R, VALLET V etal.: Establishment of renal proximal tubule cell lines by targeted oncogenesis in transgenic mice using the L-pyruvate kinase-SV40 (T) antigen hybrid gene. J. Cell Sci. (1993) 104( Pt 3):695-704.
   PubMed Web of Science ®Google Scholar
• HIRSCH-ERNST KI, PAUL D, KAHLGF, HOHNE MW: Expression of c-fos and c-myc protooncogenes in an immortalized hepatocyte line harbouring SV40 T antigen and hGH as transgenes. Transgenic Res. (1993) 2(2):101-108.
   PubMed Web of Science ®Google Scholar
• BELLAMY CO, CLARKE AR, WYLLIEAH, HARRISON DJ: p53 Deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage. FASEB J. (1997) 11(7):591-599.
   PubMedGoogle Scholar
• TSUKADA T, TOMOOKA Y, TAKAI S etal.: Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene (1993) 8(12):3313-3322.
   PubMed Web of Science ®Google Scholar
• KLOCKE R, GOMEZ-LECHON MJ, EHRHARDT A etal.: Establishment and characterization of immortal hepatocytes derived from various transgenic mouse lines. Biochem. Biophys. Res. Commun. (2002) 294(4):864-871.
   PubMed Web of Science ®Google Scholar
• SHIMOJI M, HATTORI K, ITOH S etal.: Establishment of immortal hepatocytes from a CYP3A7-transgenic/p53-knockout mouse. Biochem. Biophys. Res. Commun. (1995) 217(3):1001-1005.
   PubMed Web of Science ®Google Scholar
• PALMITER RD, CHEN HY, MESSINGA, BRINSTER RL: SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice. Nature (1985) 316(6027):457-460.
   PubMed Web of Science ®Google Scholar
• PRIESNER C, HESSE F, WINDGASSEND etal.: Liver-specific physiology of immortal, functionally differentiated hepatocytes and of deficient hepatocyte-like variants. InVitro Cell Dev. Biol. Anim. (2004) 40(10):318-330.
   PubMed Web of Science ®Google Scholar
• SAKUMA T, TAKAI M, ENDO Y etal.: A novel female-specific member of the CYP3A gene subfamily in the mouse liver. Arch. Biochem. Biophys. (2000) 377(1):153-162.
   PubMed Web of Science ®Google Scholar
• DONATO MT, KLOCKE R, CASTELLJV etal.: Constitutive and inducible expression of CYP enzymes in immortal hepatocytes derived from SV40 transgenic mice. Xenobiotica (2003) 33(5):459-473.
   PubMed Web of Science ®Google Scholar
• ANTOINE B, LEVRAT F, VALLET V etal.: Gene expression in hepatocyte-like lines established by targeted carcinogenesis in transgenic mice. Exp. Cell Res. (1992) 200(1):175-185.
   PubMed Web of Science ®Google Scholar
• WIDMAN LE, GOLDEN JJ, CHASINLA: Immortalization of normal liver functions in cell culture: rat hepatocyte-hepatoma cell hybrids expressing ornithine carbamoyltransferase activity. J. Cell. Physiol. (1979) 100(3):391-400.
   PubMed Web of Science ®Google Scholar
• PETZINGER E, FOLLMANN W, BLUMRICH M etal.: Immortalization of rat hepatocytes by fusion with hepatoma cells. I. Cloning of a hepatocytoma cell line with bile canaliculi. Eur. J. Cell Biol. (1994) 64(2):328-338.
   PubMed Web of Science ®Google Scholar
• KATZ N, IMMENSCHUH S, GERBRACHT U etal.: Hormone-sensitive carbohydrate metabolism in rat hepatocyte-hepatoma hybrid cells. Eur. J. Cell Biol. (1992) 57(1):117-123.
   PubMed Web of Science ®Google Scholar
• IMMENSCHUH S, PETZINGER E, KATZ N: Secretion of plasma proteins and its insulin-dependent regulation in rat hepatocyte-hepatoma hybrid cells. Eur. J. Cell Biol. (1993) 60(2):256-260.
   PubMed Web of Science ®Google Scholar
• REUNER KH, VAN DER DOES A, DUNKER P etal.: Microinjection of ADP-ribosylated actin inhibits actin synthesis in hepatocyte-hepatoma hybrid cells. Biochem. J. (1996) 319( Pt 3):843-849.
   PubMed Web of Science ®Google Scholar
• CRESPI CL, MILLER VP: The use of heterologously expressed drug metabolizing enzymes-state of the art and prospects for the future. Pharmacol. Ther. (1999) 84(2):121-131.
   PubMed Web of Science ®Google Scholar
• GONZALEZ FJ, KORZEKWA KR: Cytochromes P450 expression systems. Ann. Rev. Pharmacol. Toxicol. (1995) 35:369-390.
   PubMed Web of Science ®Google Scholar
• SAWADA M, KAMATAKI T: Genetically engineered cells stably expressing cytochrome P450 and their application to mutagen assays. Mutat. Res. (1998) 411(1):19-43.
   PubMed Web of Science ®Google Scholar
• PRITCHARD MP, GLANCEY MJ, BLAKE JA etal.: Functional co-expression of CYP2D6 and human NADPH-cytochrome P450 reductase in Escherichia coli. Pharmacogenetics (1998) 8(1):33-42.
   PubMedGoogle Scholar
• CHEN L, BUTERS JT, HARDWICK JP etal.: Coexpression of cytochrome P4502A6 and human NADPH-P450 oxidoreductase in the baculovirus system. Drug Metab. Dispos. (1997) 25(4):399-405.
   PubMed Web of Science ®Google Scholar
• LANGENBACH R, SMITH PB, CRESPIC: Recombinant DNA approaches for the development of metabolic systems used in invitro toxicology. Mutat. Res. (1992) 277(3):251-275.
   PubMed Web of Science ®Google Scholar
• TOWNSEND AJ, KININGHAM KK, ST CLAIR D etal.: Symposium overview: Characterization of xenobiotic metabolizing enzyme function using heterologous expression systems. Toxicol. Sci. (1999) 48(2):143-150.
   PubMed Web of Science ®Google Scholar
• DICKINS M: Induction of cytochromes P450. Curr. Top. Med. Chem. (2004) 4(16):1745-1766.
   PubMed Web of Science ®Google Scholar
• CUI X, PALAMANDA J, NORTON L etal.: A high-throughput cell-based reporter gene system for measurement of CYP1A1 induction. J. Pharmacol. Toxicol. Methods (2002) 47(3):143-151.
   PubMed Web of Science ®Google Scholar
• OGG MS, GRAY TJ, GIBSON GG: Development of an invitro reporter gene assay to assess xenobiotic induction of the human CYP3A4 gene. Eur. J. Drug Metab. Pharmacokinet. (1997) 22(4):311-313.
   PubMed Web of Science ®Google Scholar
• OGG MS, WILLIAMS JM, TARBIT M etal.: A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene invitro. Xenobiotica (1999) 29(3):269-279.
   PubMed Web of Science ®Google Scholar
• SCHREM H, KLEMPNAUER J, BORLAK J: Liver-enriched transcription factors in liver function and development. Part II: the C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacol. Rev. (2004) 56(2):291-330.
   PubMed Web of Science ®Google Scholar
• SCHREM H, KLEMPNAUER J, BORLAK J: Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol. Rev. (2002) 54(1):129-158.
   PubMed Web of Science ®Google Scholar
• LAI E, CLARK K, BURLEY S, DARNELLJ: Hepatocyte nuclear factor 3/fork head or winged helix proteins: a family of transcription factors of diverse biologic function. Proc. Natl. Acad. Sci. USA (1993) 90(22):10421-10423.
   PubMed Web of Science ®Google Scholar
• KAESTNER K, HIEMISCH H, SCHUTZG: Targeted disruption of the gene encoding hepatocyte nuclear factor 3gamma results in reduced transcription of hepatocyte-specific genes. Mol. Cell. Biol. (1998) 18(7):4245-4251.
   PubMed Web of Science ®Google Scholar
• CROWE A, SANG L, LI K etal.: Hepatocyte nuclear factor 3 relieves chromatin-mediated repression of the alpha-fetoprotein gene. J. Biol. Chem. (1999) 274(35):25113-25120.
   PubMed Web of Science ®Google Scholar
• BORT R, GOMEZ-LECHON MJ, CASTELL JV, JOVER R: Role of hepatocyte nuclear factor 3 in the expression of human CYP2C genes. Arch. Biochem. Biophys. (2004) 426(1):63-72.
   PubMed Web of Science ®Google Scholar
• DUNCAN S, NAVAS M, DUFORT D, ROSSANT J, STOFFEL M: Regulation of a transcription factor network required for differentiation and metabolism. Science (1998) 281(5377):692-695.
   PubMed Web of Science ®Google Scholar
• TRONCHE F, YANIV M: HNF1, a homeoprotein member of the hepatic transcription regulatory network. Bioessays (1992) 14(9):579-587.
   PubMed Web of Science ®Google Scholar
• CASTELL JV, HERNANDEZ D, GOMEZ-FOIX AM etal.: Adenovirus-mediated gene transfer into human hepatocytes: analysis of the biochemical functionality of transduced cells. Gene Ther. (1997) 4(5):455-464.
   PubMed Web of Science ®Google Scholar
• RODRIGUEZ-ANTONA C, BORT R, JOVER R etal.: Transcriptional regulation of human CYP3A4 basal expression by CCAAT enhancer-binding protein- and hepatocyte nuclear factor-3. Mol. Pharmacol. (2003) 63(5):1180-1189.
   PubMed Web of Science ®Google Scholar
• MANGELSDORF D, EVANS R: The RXR heterodimers and orphan receptors. Cell (1995) 83:841-850.
   PubMed Web of Science ®Google Scholar
• HERTZ R, MAGENHEIM J, BERMAN I, BAR-TANA J: Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4. Nature (1998) 392(6675):512-516.
   PubMed Web of Science ®Google Scholar
• DUDA K, CHI YI, SHOELSON SE: Structural basis for HNF-4 activation by ligand and coactivator binding. J. Biol. Chem. (2004) 279(22):23311-23316.
   PubMed Web of Science ®Google Scholar
• SLADEK FM, ZHONG WM, LAI E, DARNELL JE Jr: Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. (1990) 4(12B):2353-2365.
   PubMed Web of Science ®Google Scholar
• JIANG G, NEPOMUCENO L, HOPKINS K, SLADEK FM: Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors. Mol. Cell. Biol. (1995) 15(9):5131-5143.
   PubMed Web of Science ®Google Scholar
• YAMAGATA K, FURUTA H, ODA N etal.: Mutations in the hepatocyte nuclear factor-4 gene in maturity-onset diabetes of the young (MODY1). Nature (1996) 384(6608):458-460.
   PubMed Web of Science ®Google Scholar
• HADZOPOULOU-CLADARAS M, KISTANOVA E, EVAGELOPOULOU C etal.: Functional domains of the nuclear receptor hepatocyte nuclear factor 4. J. Biol. Chem. (1997) 1(272):539-550.
   Google Scholar
• JOVER R, BORT R, GOMEZ-LECHON MJ, CASTELL JV: Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting. Hepatology (2001) 33(3):668-675.
   PubMed Web of Science ®Google Scholar
• LEE YK, DELL H, DOWHAN DH, HADZOPOULOU-CLADARAS M, MOORE DD: The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression. Mol. Cell. Biol. (2000) 20(1):187-195.
   PubMed Web of Science ®Google Scholar
• XU J, LI Q: Review of the invivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol. (2003) 17(9):1681-1692.
   PubMed Web of Science ®Google Scholar
• DESCOMBES P, SCHIBLER U: A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell (1991) 67(3):569-579.
   PubMed Web of Science ®Google Scholar
• OSSIPOW V, DESCOMBES P, SCHIBLER U: CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc. Natl. Acad. Sci. USA (1993) 90(17):8219-8223.
   PubMed Web of Science ®Google Scholar
• TRAUTWEIN C, RAKEMANN T, PIETRANGELO A etal.: C/EBP-/LAP controls down-regulation of albumin gene transcription during liver regeneration. J. Biol. Chem. (1996) 271(36):22262-22270.
   PubMed Web of Science ®Google Scholar
• WELM A, MACKEY S, TIMCHENKO L, DARLINGTON G, TIMCHENK N: Translational induction of liver-enriched transcriptional inhibitory protein during acute phase response leads to repression of CCAAT/enhancer binding protein- mRNA. J. Biol. Chem. (2000) 275(35):27406-27413.
   PubMed Web of Science ®Google Scholar
• ZAHNOW C, YOUNES P, LAUCIRIC R, ROSEN J: Overexpression of C/EBP-LIP, a naturally occurring,dominant-negative transcription factor, in human breast cancer. J. Natl. Cancer Inst. (1997) 89(24):1887-1891.
   PubMed Web of Science ®Google Scholar
• JOVER R, BORT R, GOMEZ-LECHON MJ, CASTELL JV: Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved. FASEB J. (2002) 16(13):1799-1801.
   PubMed Web of Science ®Google Scholar
• MARTINEZ-JIMENEZ CP, GOMEZ-LECHON MJ, CASTELL JV, JOVER R: Transcriptional regulation of the human hepatic CYP3A4: identification of a new distal enhancer region responsive to CCAAT/enhancer-binding protein () isoforms (liver activating protein and liver inhibitory protein). Mol. Pharmacol. (2005) 67(6):2088-2101.
   PubMed Web of Science ®Google Scholar
• TSAI SY, TSAI MJ: Chick ovalbumin upstream promoter-transcription factors (COUP-TFs): coming of age. Endocr. Rev. (1997) 18(2):229-240.
   PubMed Web of Science ®Google Scholar
• PARK JI, TSAI SY, TSAI MJ: Molecular mechanism of chicken ovalbumin upstream promoter-transcription factor (COUP-TF) actions. Keio J. Med. (2003) 52(3):174-181.
   PubMedGoogle Scholar
• MIYAJIMA N, KADOWAKI Y, FUKUSHIGE S etal.: Identification of two novel members of erbA superfamily by molecular cloning: the gene products of the two are highly related to each other. Nucleic Acids Res. (1988) 16(23):11057-11074.
   PubMed Web of Science ®Google Scholar
• KIMURA A, NISHIYORI A, MURAKAMIT etal.: Chicken ovalbumin upstream promoter-transcription factor (COUP-TF) represses transcription from the promoter of the gene for ornithine transcarbamylase in a manner antagonistic to hepatocyte nuclear factor-4 (HNF-4). J. Biol. Chem. (1993) 268(15):11125-11133.
   PubMed Web of Science ®Google Scholar
• BURKE LJ, BANIAHMAD A: Co-repressors 2000. FASEB J. (2000) 14(13):1876-1888.
   PubMed Web of Science ®Google Scholar
• RAZIN A, RIGGS A: DNA methylation and gene function. Science (1980) 210(4470):604-610.
   PubMed Web of Science ®Google Scholar
• KNOEPFLER PS, EISENMAN RN: Sin meets NuRD and other tails of repression. Cell (1999) 99(5):447-450.
   PubMed Web of Science ®Google Scholar
• NAN X, NG H, JOHNSON C etal.: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 393(6683):386-389.
   PubMed Web of Science ®Google Scholar
• JONES P, VEENSTRA G, WADE P etal.: Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. (1998) 19(2):187-191.
   PubMed Web of Science ®Google Scholar
• KUO MH, ALLIS CD: Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays (1998) 20(8):615-626.
   PubMed Web of Science ®Google Scholar
• COLLINGWOOD T, URNOV F, WOLFFE A: Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J. Mol. Endocrinol. (1999) 23(3):255-275.
   PubMed Web of Science ®Google Scholar
• BROWN C, LECHNER T, HOWE L, WORKMAN J: The many HATs of transcription coactivators. Trends Biochem. Sci. (2000) 25(1):15-19.
   PubMed Web of Science ®Google Scholar
• KUMAR R, WANG RA, BARNES CJ: Coregulators and chromatin remodeling in transcriptional control. Mol. Carcinog. (2004) 41(4):221-230.
   PubMed Web of Science ®Google Scholar
• STRUHL K: Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. (1998) 12:599-606.
   PubMed Web of Science ®Google Scholar
• MINUCCI S, HORN V, BHATTACHARYYA N etal.: A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA (1997) 94:11295-11300.
   PubMed Web of Science ®Google Scholar
• PAPELEU P, VANHAECKE T, ELAUT G etal.: Differential effects of histone deacetylase inhibitors in tumor and normal cells-what is the toxicological relevance? Crit. Rev. Toxicol. (2005) 35(4):363-378.
   PubMed Web of Science ®Google Scholar
• MONNERET C: Histone deacetylase inhibitors. Eur J. Med. Chem. (2005) 40(1):1-13.
   PubMed Web of Science ®Google Scholar
• FORBES S, VIG P, POULSOM R, THOMAS H, ALISON M: Hepatic stem cells. J. Pathol. (2002) 197(4):510-518.
   PubMed Web of Science ®Google Scholar
• PETERSEN BE, BOWEN WC, PATRENE KD etal.: Bone marrow as a potential source of hepatic oval cells. Science (1999) 284(5417):1168-1170.
   PubMed Web of Science ®Google Scholar
• JACKSON KA, MI T, GOODELL MA: Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc. Natl. Acad. Sci. USA (1999) 96(25):14482-14486.
   PubMed Web of Science ®Google Scholar
• ALISON MR, POULSOM R, JEFFERY R etal.: Hepatocytes from non-hepatic adult stem cells. Nature (2000) 406(6793):257.
   PubMed Web of Science ®Google Scholar
• THEISE ND, BADVE S, SAXENA R etal.: Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology (2000) 31(1):235-240.
   PubMed Web of Science ®Google Scholar
• THEISE ND, NIMMAKAYALU M, GARDNER R etal.: Liver from bone marrow in humans. Hepatology (2000) 32(1):11-16.
   PubMed Web of Science ®Google Scholar
• GOLDING M, SARRAF CE, LALANI EN etal.: Oval cell differentiation into hepatocytes in the acetylaminofluorene-treated regenerating rat liver. Hepatology (1995) 22(4 Pt 1):1243-1253.
   PubMed Web of Science ®Google Scholar
• PAKU S, SCHNUR J, NAGY P, THORGEIRSSON SS: Origin and structural evolution of the early proliferating oval cells in rat liver. Am. J. Pathol. (2001) 158(4):1313-1323.
   PubMed Web of Science ®Google Scholar
• ALISON M, GOLDING M, LALANI EN etal.: Wholesale hepatocytic differentiation in the rat from ductular oval cells, the progeny of biliary stem cells. J. Hepatol. (1997) 26(2):343-352.
   PubMed Web of Science ®Google Scholar
• MITAKA T, SATO F, MIZUGUCHI T, YOKONO T, MOCHIZUKI Y: Reconstruction of hepatic organoid by rat small hepatocytes and hepatic nonparenchymal cells. Hepatology (1999) 29(1):111-125.
   PubMed Web of Science ®Google Scholar
• WATT FM, HOGAN BL: Out of eden: stem cells and their niches. Science (2000) 287(5457):1427-1430.
   PubMed Web of Science ®Google Scholar
• DAHLKE MH, POPP FC, LARSEN S, SCHLITT HJ, RASKO JE: Stem cell therapy of the liver-fusion or fiction? Liver Transpl. (2004) 10(4):471-479.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ RE, REYES M, KOODIE L etal.: Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J. Clin. Invest. (2002) 109(10):1291-1302.
   PubMed Web of Science ®Google Scholar
• TOSH D, SHEN CN, SLACK JM: Conversion of pancreatic cells to hepatocytes. Biochem. Soc. Trans. (2002) 30(2):51-55.
   PubMed Web of Science ®Google Scholar
• MAREK CJ, CAMERON GA, ELRICKLJ, HAWKSWORTH GM, WRIGHT MC: Generation of hepatocytes expressing functional cytochromes P450 from a pancreatic progenitor cell line invitro. Biochem. J. (2003) 370(Pt3):763-769.
   PubMed Web of Science ®Google Scholar
• SHEN CN, SLACK JM, TOSH D: Molecular basis of transdifferentiation of pancreas to liver. Nat. Cell Biol. (2000) 2(12):879-887.
   PubMed Web of Science ®Google Scholar
• LARDON J, DE BREUCK S, ROOMANI etal.: Plasticity in the adult rat pancreas: transdifferentiation of exocrine to hepatocyte-like cells in primary culture. Hepatology (2004) 39(6):1499-1507.
   PubMed Web of Science ®Google Scholar
• KURASH JK, SHEN CN, TOSH D: Induction and regulation of acute phase proteins in transdifferentiated hepatocytes. Exp. Cell Res. (2004) 292(2):342-358.
   PubMed Web of Science ®Google Scholar
• LEE KD, KUO TK, WHANG-PENG J etal.: Invitro hepatic differentiation of human mesenchymal stem cells. Hepatology (2004) 40(6):1275-1284.
   PubMed Web of Science ®Google Scholar
• SEO MJ, SUH SY, BAE YC, JUNG JS: Differentiation of human adipose stromal cells into hepatic lineage invitro and invivo. Biochem. Biophys. Res. Commun. (2005) 328(1):258-264.
   PubMed Web of Science ®Google Scholar
• KANIA G, BLYSZCZUK P, JOCHHEIMA, OTT M, WOBUS AM: Generation of glycogen- and albumin-producing hepatocyte-like cells from embryonic stem cells. Biol. Chem. (2004) 385(10):943-953.
   PubMed Web of Science ®Google Scholar
• LAVON N, YANUKA O, BENVENISTYN: Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation (2004) 72(5):230-238.
   PubMed Web of Science ®Google Scholar
• RAMBHATLA L, CHIU CP, KUNDU P, PENG Y, CARPENTER MK: Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant. (2003) 12(1):1-11.
   PubMed Web of Science ®Google Scholar
• BEAUNE PH, KREMERS PG, KAMINSKY LS etal.: Comparison of monooxygenase activities and cytochrome P450 isozyme concentrations in human liver microsomes. Drug Metab. Dispos. (1986) 14(4):437-442.
   PubMed Web of Science ®Google Scholar
• MONTEITH DK, MICHALOPOULOSG, STROM SC: Conjugation of chemical carcinogens by primary cultures of human hepatocytes. Xenobiotica (1990) 20(8):753-763.
   PubMed Web of Science ®Google Scholar
• ROE AL, SNAWDER JE, BENSON RW, ROBERTS DW, CASCIANO DA: HepG2 cells: an invitro model for P450-dependent metabolism of acetaminophen. Biochem. Biophys. Res. Commun. (1993) 190(1):15-19.
   PubMed Web of Science ®Google Scholar
• DOOSTDAR H, GRANT MH, MELVINWT, WOLF CR, BURKE MD: The effects of inducing agents on cytochrome P450 and UDP-glucuronyltransferase activities in human HEPG2 hepatoma cells. Biochem. Pharmacol. (1993) 46(4):629-635.
   PubMed Web of Science ®Google Scholar
• GRANT MH, DUTHIE SJ, GRAY AG, BURKE MD: Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell line. Biochem. Pharmacol. (1988) 37(21):4111-4116.
   PubMed Web of Science ®Google Scholar
• DHARMESH SM, SKELTON TP, BAENZIGER JU: Co-ordinate and restricted expression of the ProXaaArg/Lys-specific GalNAc-transferase and the GalNAc- 1,4GlcNAc- 1,2Man--4-sulfotransferase. J. Biol. Chem. (1993) 268(23):17096-17102.
   PubMed Web of Science ®Google Scholar
• GLATT H, GEMPERLEIN I, SETIABUDI F, PLATT KL, OESCH F: Expression of xenobiotic-metabolizing enzymes in propagatable cell cultures and induction of micronuclei by 13 compounds. Mutagenesis (1990) 5(3):241-249.
   PubMed Web of Science ®Google Scholar
• LIMBOSCH S: Benzo[a]pyrene- and aldrin-metabolizing activities in cultured human and rat hepatoma cell lines. J. Natl. Cancer Inst. (1983) 71(2):281-286.
   PubMed Web of Science ®Google Scholar
• FUKAYA K, ASAHI S, NAGAMORI S etal.: Establishment of a human hepatocyte line (OUMS-29) having CYP 1A1 and 1A2 activities from fetal liver tissue by transfection of SV40 LT. InVitro Cell Dev. Biol. Anim. (2001) 37(5):266-269.
   PubMed Web of Science ®Google Scholar
• MIYAZAKI M, MIHARA K, BAI L etal.: Immortalization of epithelial-like cells from human liver tissue with SV40 T-antigen gene. Exp. Cell Res. (1993) 206(1):27-35.
   PubMed Web of Science ®Google Scholar
• PFEIFER AM, COLE KE, SMOOT DT etal.: Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc. Natl. Acad. Sci. USA (1993) 90(11):5123-5127.
   PubMed Web of Science ®Google Scholar
• SCHIPPERS IJ, MOSHAGE H, ROELOFSEN H etal.: Immortalized human hepatocytes as a tool for the study of hepatocytic (de-)differentiation. Cell Biol. Toxicol. (1997) 13(4-5):375-386.
   PubMed Web of Science ®Google Scholar
• HERING S, GRIFFIN BE, STRAUSS M: Immortalization of human fetal sinusoidal liver cells by polyoma virus large T antigen. Exp. Cell Res. (1991) 195(1):1-7.
   PubMed Web of Science ®Google Scholar
• RAY RB, MEYER K, RAY R: Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology (2000) 271(1):197-204.
   PubMed Web of Science ®Google Scholar
• CAI J, ITO M, WESTERMAN KA etal.: Construction of a non-tumorigenic rat hepatocyte cell line for transplantation: reversal of hepatocyte immortalization by site-specific excision of the SV40 T antigen. J. Hepatol. (2000) 33(5):701-708.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI N, NOGUCHI H, WESTERMAN KA etal.: Cre/loxP-based reversible immortalization of human hepatocytes. Cell Transplant. (2001) 10(4-5):383-386.
   PubMed Web of Science ®Google Scholar
• KIM BH, SUNG SR, CHOI EH etal.: Dedifferentiation of conditionally immortalized hepatocytes with long-term invitro passage. Exp. Mol. Med. (2000) 32(1):29-37.
   PubMed Web of Science ®Google Scholar
• SMALLEY M, LEIPER K, TOOTLE R etal.: Immortalization of human hepatocytes by temperature-sensitive SV40 large-T antigen. InVitro Cell Dev. Biol. Anim. (2001) 37(3):166-168.
   PubMed Web of Science ®Google Scholar
• UTESCH D, ARAND M, THOMAS H, PETZINGER E, OESCH F: Xenobiotic-metabolizing enzyme activities in hybrid cell lines established by fusion of primary rat liver parenchymal cells with hepatoma cells. Xenobiotica (1992) 22(12):1451-1457.
   PubMed Web of Science ®Google Scholar
• AIUTI A, CICCHINI C, BERNARDINI S etal.: Hematopoietic support and cytokine expression of murine-stable hepatocyte cell lines (MMH). Hepatology (1998) 28(6):1645-1654.
   PubMed Web of Science ®Google Scholar
• LITTLEWOOD TD, HANCOCK DC, DANIELIAN PS, PARKER MG, EVANGI: A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. (1995) 23(10):1686-1690.
   PubMed Web of Science ®Google Scholar
• MIKULA M, FUCHS E, HUBER H etal.: Immortalized p19ARF null hepatocytes restore liver injury and generate hepatic progenitors after transplantation. Hepatology (2004) 39(3):628-634.
   PubMed Web of Science ®Google Scholar
• CRESPI CL, LANGENBACH R, PENMAN BW: The development of a panel of human cell lines expressing specific human cytochrome P450 cDNAs. Prog. Clin. Biol. Res. (1990) 340B:97-106.
   PubMedGoogle Scholar
• CRESPI CL, LANGENBACH R, PENMAN BW: Human cell lines, derived from AHH-1 TK+/- human lymphoblasts, genetically engineered for expression of cytochromes P450. Toxicology (1993) 82(1-3):89-104.
   PubMed Web of Science ®Google Scholar
• DELESCLUSE C, LEDIRAC N, LI R etal.: Induction of cytochrome P450 1A1 gene expression, oxidative stress, and genotoxicity by carbaryl and thiabendazole in transfected human HepG2 and lymphoblastoid cells. Biochem. Pharmacol. (2001) 61(4):399-407.
   PubMed Web of Science ®Google Scholar
• WU J, DONG H, CAI Z, YU Y: Stable expression of human cytochrome CYP2B6 and CYP1A1 in Chinese hamster CHL cells: their use in micronucleus assays. Chin. Med. Sci. J. (1997) 12(3):148-155.
   PubMedGoogle Scholar
• YOSHITOMI S, IKEMOTO K, TAKAHASHI J etal.: Establishment of the transformants expressing human cytochrome P450 subtypes in HepG2, and their applications on drug metabolism and toxicology. Toxicol. InVitro (2001) 15(3):245-256.
   PubMed Web of Science ®Google Scholar
• CRESPI CL, GONZALEZ FJ, STEIMELDT etal.: A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing. Chem. Res. Toxicol. (1991) 4(5):566-572.
   PubMed Web of Science ®Google Scholar
• LUCH A, COFFING SL, TANG YM etal.: Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene. Chem. Res. Toxicol. (1998) 11(6):686-695.
   PubMed Web of Science ®Google Scholar
• ZHU GJ, YU YN, LI X, QIAN YL: Cloning of cytochrome P450 2C9 cDNA from human liver and its expression in CHL cells. World J. Gastroenterol. (2002) 8(2):318-322.
   PubMed Web of Science ®Google Scholar
• ZHU-GE J, YU YN, QIAN YL, LI X: Establishment of a transgenic cell line stably expressing human cytochrome P450 2C18 and identification of a CYP2C18 clone with exon 5 missing. World J. Gastroenterol. (2002) 8(5):888-892.
   PubMed Web of Science ®Google Scholar
• ZHUGE J, YU YN, WU XD: Stable expression of human cytochrome P450 2D6*10 in HepG2 cells. World J. Gastroenterol. (2004) 10(2):234-237.
   PubMed Web of Science ®Google Scholar
• ZHUGE J, LUO Y, YU YN: Heterologous expression of human cytochrome P450 2E1 in HepG2 cell line. World J. Gastroenterol. (2003) 9(12):2732-2736.
   PubMed Web of Science ®Google Scholar
• CEDERBAUM AI: Ethanol-related cytotoxicity catalyzed by CYP2E1-dependent generation of reactive oxygen intermediates in transduced HepG2 cells. Biofactors (1998) 8(1-2):93-96.
   PubMed Web of Science ®Google Scholar
• DAI Y, RASHBA-STEP J, CEDERBAUMAI: Stable expression of human cytochrome P4502E1 in HepG2 cells: characterization of catalytic activities and production of reactive oxygen intermediates. Biochemistry (1993) 32(27):6928-6937.
   PubMed Web of Science ®Google Scholar
• TAKAHASHI S, TAKAHASHI T, MIZOBUCHI S etal.: CYP2E1 overexpression up-regulates both non-specific -aminolevulinate synthase and heme oxygenase-1 in the human hepatoma cell line HLE/2E1. Int. J. Mol. Med. (2003) 11(1):57-62.
   PubMed Web of Science ®Google Scholar
• CHEN Q, WU J, YU Y: [Establishment of transgenic cell line CHL-3A4 and its metabolic activation]. Zhonghua Yu Fang Yi Xue Za Zhi (1998) 32(5):281-284.
   PubMedGoogle Scholar
• SMITH PB, CRESPI C: Thiourea toxicity in mouse C3H/10T1/2 cells expressing human flavin-dependent monooxygenase 3. Biochem. Pharmacol. (2002) 63(11):1941-1948.
   PubMed Web of Science ®Google Scholar
• FIELDS WR, MORROW CS, DOSS AJ etal.: Overexpression of stably transfected human glutathione S-transferase P1-1 protects against DNA damage by benzo[a]pyrene diol-epoxide in human T47D cells. Mol. Pharmacol. (1998) 54(2):298-304.
   PubMed Web of Science ®Google Scholar
• LI X, YU YN, ZHU GJ, QIAN YL: Cloning of UGT1A9 cDNA from liver tissues and its expression in CHL cells. World J. Gastroenterol. (2001) 7(6):841-845.
   PubMed Web of Science ®Google Scholar
• BELANGER G, BEAULIEU M, LEVESQUE E, HUM DW, BELANGERA: Expression and characterization of a novel UDP-glucuronosyltransferase, UGT2B9, from cynomolgus monkey. DNA Cell Biol. (1997) 16(10):1195-1205.
   PubMed Web of Science ®Google Scholar
• SUEYOSHI T, KAWAMOTO T, ZELKOI, HONKAKOSKI P, NEGISHIM: The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J. Biol. Chem. (1999) 274(10):6043-6046.
   PubMed Web of Science ®Google Scholar
• LEMAIRE G, DE SOUSA G, RAHMANIR: A PXR reporter gene assay in a stable cell culture system: CYP3A4 and CYP2B6 induction by pesticides. Biochem. Pharmacol. (2004) 68(12):2347-2358.
   PubMed Web of Science ®Google Scholar
• SEIMANDI M, LEMAIRE G, PILLON A etal.: Differential responses of PPAR, PPAR, and PPAR reporter cell lines to selective PPAR synthetic ligands. Anal. Biochem. (2005) 344(1):8-15.
   PubMed Web of Science ®Google Scholar